Chaitenya Verma

Chaitenya Verma's work spans infectious disease immunology, cancer biology, and laboratory diagnostic methods, with particular attention to how immune signaling molecules (like Toll-like receptors and cytokines) influence conditions such as HIV/TB co-infection, lung cancer, and colon cancer. The research also includes practical tool development, such as nanoparticle-based methods for extracting DNA from blood and saliva samples, and reviews of emerging therapies including CAR-T cell gene therapy, cancer vaccines, and drug repurposing. This is a broad, multi-topic portfolio combining bench immunology, oncology biomarker studies, and applied diagnostic/forensic methodology.

Publication output grew steadily from 2017 to a peak around 2023, followed by a slight decline in more recent years while remaining well above earlier levels.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026